Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Albemarle Corp. Stock Slides 4.6%, Underperforms Peers

Albemarle Corp. Stock Slides 4.6%, Underperforms Peers

Dow JonesDow Jones2026/09/24 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Albemarle Corp. shed 4.6% to $108.25 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,704.13 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.

This was the stock's second consecutive day of losses.

Albemarle Corp. closed 51.0% short of its 52-week high of $221.00, which the company reached on May 7th.

The stock underperformed when compared to some of its peers, as Avantor Inc. rose 4.2% to $15.38, Celanese Corp. fell 1.9% to $47.56, and Eastman Chemical Co. fell 0.91% to $66.19.

Trading volume totaled 2.5 million, compared to the 50-day average of 2.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 24, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Vietnam VN Index closed down 0.6%

格隆汇•2026/10/26 08:09
Vietnam VN Index closed down 0.6%

Windward Bio (WWB.US) plans to list in the US and aims to raise up to 100 million dollars, with multiple drugs licensed to Chinese pharmaceutical companies.

Windward Bio Group filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to 100 million dollars.

智通财经•2026/10/26 07:31
Windward Bio (WWB.US) plans to list in the US and aims to raise up to 100 million dollars, with multiple drugs licensed to Chinese pharmaceutical companies.

A Contrarian Amid the Selloff in French Bonds: 370 billion AUD Pension Fund Increases Holdings, Betting That Fiscal Risks Are Overestimated

Australia's second largest pension fund is buying French government bonds. The institution believes that the market has overreacted in pricing France's fiscal predicament and the European Central Bank's interest rate hike outlook.

智通财经•2026/10/26 07:21